Khiron Life Scie Stock Price, News & Analysis
KHRNF
OTC
Company Description
Khiron Life Sciences Corp, traded as KHRNF, is a prominent global medical cannabis firm with operations in Latin America and Europe. With fully-owned medical health clinics and exclusive telemedicine platforms, Khiron integrates a patient-centered approach, physician education programs, scientific proficiency, product innovation, and accessibility creation to increase prescriptions and brand loyalty among patients worldwide. The company operates in Colombia, Germany, the UK, Switzerland, Peru, and Brazil. Led by CEO Alvaro Torres, Khiron is supported by a seasoned executive team and board of directors.
Stock Performance
$—
0.00%
0.00
Last updated:
- %
Performance 1 year
$7.0M
Market Cap
232.4M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for Khiron Life Scie.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is the current stock price of Khiron Life Scie (KHRNF)?
The current stock price of Khiron Life Scie (KHRNF) is $0.000001 as of April 2, 2025.
What is the market cap of Khiron Life Scie (KHRNF)?
The market cap of Khiron Life Scie (KHRNF) is approximately 7.0M.
What is Khiron Life Sciences Corp known for?
Khiron is a leading global medical cannabis company with operations in Latin America and Europe.
Where does Khiron have a sales presence?
Khiron has a sales presence in Colombia, Germany, the UK, Switzerland, Peru, and Brazil.
Who leads Khiron Life Sciences Corp?
Khiron is spearheaded by CEO Alvaro Torres, along with an experienced executive team and board of directors.
What sets Khiron apart in the medical cannabis industry?
Khiron focuses on a patient-oriented approach, physician education programs, scientific expertise, product innovation, and accessibility creation.
What are Khiron's core operations?
Khiron's core operations include wholly-owned medical health clinics and proprietary telemedicine platforms.
Which regions does Khiron primarily operate in?
Khiron primarily operates in Latin America and Europe.
How does Khiron drive prescriptions and brand loyalty?
Khiron drives prescriptions and brand loyalty through a patient-centered approach and product innovation.
What recent achievement did Khiron announce?
Khiron announced the Restated Purchase Agreement for the sale of its European subsidiaries.
Who controls 2518542 Alberta Ltd?
2518542 Alberta Ltd is controlled by Avonlea Drewry Holdings Inc.
What is the Manager Expenses for the Management Services?
The Manager Expenses is a management fee equal to the monthly net income of the Subject Subsidiaries, plus reasonable expenses.